In conclusion, this study characterizes relapse patterns and prognostic determinants in pediatric ALL, highlighting the interplay among baseline thrombocytopenia, BCR::ABL1 (+) fusion gene, and MRD level. The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.